ImmunoPrecise Antibodies Ltd. - COM NEW (IPA)

Historical Portfolio Holders from Q4 2020 to Q2 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM NEW
Shares, excl. options Q2 2024
1.66M
Holdings value Q2 2024
$1.68M
Value change Q2 2024
-$61.1K
Grand Portfolio weight change Q2 2024
0%
Number of holders
19
Number of buys Q2 2024
8
Number of sells Q2 2024
-7
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q2 1.66M $1.68M -$61.1K $1.01 19
2024 Q1 1.67M $2.54M -$141K $1.52 24
2023 Q4 1.73M $2.95M +$618K $1.71 23
2023 Q3 1.36M $2.58M -$149K $1.83 18
2023 Q2 1.43M $4.29M -$521K $2.96 15
2023 Q1 1.61M $4.51M +$485K $2.77 16
2022 Q4 1.43M $7.44M +$67.3K $5.21 19
2022 Q3 1.42M $5.65M +$198K $3.99 17
2022 Q2 1.37M $5.28M +$174K $3.85 20
2022 Q1 1.31M $6.74M -$25.8K $5.14 17
2021 Q4 1.29M $6.95M +$287K $5.36 19
2021 Q3 1.26M $7.85M -$661K $6.22 25
2021 Q2 1.37M $8.27M -$7.04K $6.03 21
2021 Q1 1.36M $13.4M +$8M $9.82 17
2020 Q4 523K $7.83M +$7.83M $14.97 13